Monitor for adverse drug reactions such as intraocular inflammation, pigmentary changes, and macular edema. Monitor intraocular pressure every 2 to 4 weeks until target intraocular pressure is attained. Subsequently, every six months is sufficient.

For pediatric glaucoma, a 14-day home monitoring period provided a more than 90% chance of identifying an IOP spike.